United States

PETVIVO HOLDINGS, INC. LAUNCHES DIGITAL MEDIA CAMPAIGN

MINNEAPOLIS, MN, US, Nov. 29, 2021 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (“PetVivo”), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, today announces the launch of a digital…

Read More »

KoreConX Webinar: Dare to Dream

SmartBank Scales Presence in Nashville, Tennessee

Bionano Genomics Appoints Dr. Keith Gligorich, Seasoned Leader in CLIA-Certified CAP-Accredited Lab Operations, as VP Operations for Bionano Laboratories

iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021

Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer Cell Therapy CYNK-101 in First-line Advanced Her2/neu Positive Gastric and Gastroesophageal Junction Cancer

Athenex Announces UK MHRA Validation of the Marketing Authorization Application for Oral Paclitaxel and Encequidar for Review

Kratos Receives $4.1 Million Unmanned Aerial Vehicle System Award from International Customer

Avenue Therapeutics Announces FDA Advisory Committee Meeting to Review IV Tramadol NDA Tentatively Scheduled for February 15, 2022

Journey Medical Corporation Introduces Expanded Board of Directors

PubMatic Announces the Opening of New Office in Paris as Part of European Growth Strategy

Tulsa Zoo Adopts ProStar’s PointMan to Protect The Pipes, The Public, and The Penguins

Enphase Energy Technology Selected by Australian Government and Community Organizations

Chembio Diagnostics Receives SAHPRA Approval for DPP SARS-CoV-2 Antigen Test

Arterys Partners With Cercare Medical to Offer Advanced Perfusion Brain CT and MR Imaging Analysis Accelerating Access to Deep, Fast, and Reliable Insights

Piezo Motion and iMotion Inc. Announce Partnership

Praxis Precision Medicines to Present Data from Rare Disease Programs at the American Epilepsy Society 2021 Annual Meeting

Verve Therapeutics Appoints Allison Dorval, Experienced Financial Executive, as Chief Financial Officer

Vor to Participate in the JMP Securities Hematology and Oncology Summit

NV5 Awarded $4 Million in Middle East Building Engineering and Technology Projects